On May, 10 The EPS for Viveve Medical, Inc. (VIVE) Expected At $-0.42

May 3, 2018 - By Maria Fierro

Investors expect Viveve Medical, Inc. (NASDAQ:VIVE)’s quarterly earnings on May, 10., as reported by RTT. EPS of $-0.42 is 26.32 % up from 2017’s $-0.57 EPS. Last quarter $-0.53 EPS was reported. Analysts sees -20.75 % EPS growth this quarter. VIVE touched $3.47 during the last trading session after $0.09 change.Currently Viveve Medical, Inc. is downtrending after 30.87% change in last May 3, 2017. VIVE has also 105,591 shares volume. VIVE underperformed the S&P500 by 42.42%.

Viveve Medical, Inc. designs, develops, makes, and markets medical devices for the non-invasive treatment of vaginal laxity.The firm is worth $108.38 million. The firm offers Geneveve, a non-invasive solution that includes the Viveve System, a radio frequency generator; a reusable hand piece and single-use treatment tip; and other consumable accessories.Last it reported negative earnings. It markets its products through sales employees and distributors in Asia, Europe, the Middle East, Latin America, the United States, Canada, and internationally.

Viveve Medical, Inc. (NASDAQ:VIVE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: